Dicot Pharma AB OMXSTO:DICOT:
Q1 NET SALES AMOUNT TO SEK 0.0 MILLION
Q1 EARNINGS AFTER FINANCIAL ITEMS AT SEK -14.8 MILLION
Dicot Pharma B - Q1 Net Sales Amount To Sek 0.0 Million
Earlier from Dicot Pharma
- Dicot To Carry Out Rights Issue Of SEK 210 Million
- Pharma publishes its Annual Report for 2025
- Notice of annual general meeting in DICOT Pharma AB
- Dicot Pharma initiates tablet manufacturing ahead of phase 2b clinical study
- DICOT: LIB-01 demonstrated long-lasting efficacy in phase 2a, supporting further clinical development
Later from Dicot Pharma
- Report from the Annual General Meeting of Dicot Pharma
- Dicot Pharma has resolved on an 80% guaranteed rights issue of approximately SEK 210 million
- Dicot Pharma Resolves On Rights Issue Of About SEK 210 Mln
- Dicot Pharma publishes prospectus in connection with the forthcoming rights issue
- Dicot Pharma completes tablet manufacturing ahead of phase 2b clinical study
Follow Dicot Pharma into a list and get an email when it puts out news.
Follow Dicot Pharma